[HTML][HTML] mTOR substrate phosphorylation in growth control

S Battaglioni, D Benjamin, M Wälchli, T Maier, MN Hall - Cell, 2022 - cell.com
The target of rapamycin (TOR), discovered 30 years ago, is a highly conserved
serine/threonine protein kinase that plays a central role in regulating cell growth and …

The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers

J Wang, L Chen, P Qiang - Cancer cell international, 2021 - Springer
The human insulin-like growth factor 2 (IGF2) mRNA binding proteins 2 (IGF2BP2/IMP2) is
an RNA-binding protein that regulates multiple biological processes. Previously, IGF2BP2 …

Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation

H Huang, H Weng, W Sun, X Qin, H Shi, H Wu… - Nature cell …, 2018 - nature.com
Abstract N 6-methyladenosine (m6A) is the most prevalent modification in eukaryotic
messenger RNAs (mRNAs) and is interpreted by its readers, such as YTH domain …

[HTML][HTML] Molecular neurobiology of mTOR

K Switon, K Kotulska, A Janusz-Kaminska… - Neuroscience, 2017 - Elsevier
Mammalian/mechanistic target of rapamycin (mTOR) is a serine-threonine kinase that
controls several important aspects of mammalian cell function. mTOR activity is modulated …

[HTML][HTML] The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer

D Ramesh-Kumar, S Guil - Seminars in Cancer Biology, 2022 - Elsevier
RNA binding proteins that act at the post-transcriptional level display a richness of
mechanisms to modulate the transcriptional output and respond to changing cellular …

The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ

X Wang, Y Ji, P Feng, R Liu, G Li, J Zheng… - Advanced …, 2021 - Wiley Online Library
Phenotypic polarization of macrophages is regulated by a milieu of cues in the local tissue
microenvironment. Currently, little is known about how the intrinsic regulators modulate …

Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

JL Bell, K Wächter, B Mühleck, N Pazaitis… - Cellular and molecular …, 2013 - Springer
The insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1, IGF2BP2,
IGF2BP3) belong to a conserved family of RNA-binding, oncofetal proteins. Several studies …

Heterogeneous ribosomes preferentially translate distinct subpools of mRNAs genome-wide

Z Shi, K Fujii, KM Kovary, NR Genuth, HL Röst… - Molecular cell, 2017 - cell.com
Emerging studies have linked the ribosome to more selective control of gene regulation.
However, an outstanding question is whether ribosome heterogeneity at the level of core …

Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells

M Janiszewska, ML Suvà, N Riggi… - Genes & …, 2012 - genesdev.cshlp.org
Growth of numerous cancer types is believed to be driven by a subpopulation of poorly
differentiated cells, often referred to as cancer stem cells (CSCs), that have the capacity for …

[HTML][HTML] The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer

M Lederer, N Bley, C Schleifer, S Hüttelmaier - Seminars in cancer biology, 2014 - Elsevier
The post-transcriptional control of gene expression mediated by RNA-binding proteins
(RBPs), long non-coding RNAs (lncRNAs) as well as miRNAs is essential to determine …